BEGIN:VCALENDAR VERSION:2.0 PRODID:-//MDG Boston - ECPv6.18.2//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-ORIGINAL-URL:https://www.mdgboston.org X-WR-CALDESC:Events for MDG Boston REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20200308T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20201101T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20210314T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20211107T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20220313T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20221106T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20230312T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20231105T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20240310T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20241103T060000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/New_York:20230524T113000 DTEND;TZID=America/New_York:20230524T133000 DTSTAMP:20230606T222354Z CREATED:20230505T184159Z LAST-MODIFIED:20230606T222354Z UID:248950-1684927800-1684935000@www.mdgboston.org SUMMARY:Go-To-Market Strategies for Start-up Success: Beyond Regulatory and Reimbursement Milestones DESCRIPTION:Recording \n \n \n \n \n \n \n Abstract \nSuccessful exits for medtech startups have never been tougher to achieve. \n\nCost: $31 million and $94 million on average to get to market via 510(k) and PMA routes\, respectively.\nTime: 2/3 of medtech startup acquisitions occur post-commercialization.\nChallenge: 75% of first VP Sales turn over between 16 and 24 months.\n\nStrategics and investors seek evidence of market adoption despite rising commercial headwinds. \n\nMany hard-to-reach stakeholders create a complex buying process.\nHospitals are struggling financially.\nLabor and staffing challenges are overwhelming.\n\nLearn why market forces demand a more sophisticated and earlier approach to commercialization and go-to-market planning. \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Mike LeeVP of Strategy & New Business Development\, (Retired) \n \n \n \n \n \n Follow\n \n \n \n \n \n \n \n \n \n \n \n Netalie NadiviVenture Capitalist \n \n \n \n \n \n Follow\n \n \n \n \n \n \n \n \n \n \n \n Jim SurekCommercial Consultant\, SAV²R Group \n \n \n \n \n \n Follow\n \n \n \n \n \n \n \n \n \n \n \n Mike MooreExecutive Recruiter\, MJ Moore & Associates \n \n \n \n \n \n Follow\n \n \n \n \n \n \n \n \n \n \n \n MODERATOR: Tom PatzeltCommercial Consultant\, Patzelt Marketing \n \n \n \n \n \n Follow\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Agenda and DateMay 24 11:30am – 1:30pm EDT (ONLINE EVENT)• 11:30 – 12:00 General Networking• 12:00 – 1:00 Panelist Forum• 1:00 – 1:30 Meet the speakers and more networking \n  \nZoom links will be provided for all registered attendees prior to the event. URL:https://www.mdgboston.org/event/go-to-market-strategies-for-start-up-success/ LOCATION:Online CATEGORIES:Featured,Forum,MDG ATTACH;FMTTYPE=image/jpeg:https://www.mdgboston.org/wp-content/uploads/2023/05/Picture1.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20221109T163000 DTEND;TZID=America/New_York:20221109T183000 DTSTAMP:20221114T011320Z CREATED:20221019T224700Z LAST-MODIFIED:20221114T011320Z UID:246254-1668011400-1668018600@www.mdgboston.org SUMMARY:Ocular Drug Delivery & Surgical Advances DESCRIPTION:Recording\n \n \n \n \n \n \n \n \n \n \n \n Full Length\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Abstract\nDrug-Device-Robotics Combination Technologies for the Eye \nWith an increased age-related high prevalence of eye diseases\, ocular drug delivery technology innovation and robotic surgical advances present unprecedented opportunities and challenges. \nOur three distinguished speakers will share with us some of the most exciting novel ophthalmic drug delivery technologies and robotic surgical innovation in the 21st century biology-based medicine from: 1) Subretinal gene & cell delivery precision to 2) Smart micro dose eye dropper\, and 3) A minimally invasive localized suprachoroidal drug delivery route\, all of which represent the new frontier of ophthalmic therapeutic innovation via improved delivery efficiency. \nTogether\, these impressive advances are significantly advancing ophthalmic healthcare. \n  \nPanelists\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Sean Ianchulev\, MD\, MPHProf. of Ophthalmology\,Icahn School of Medicine\, Mount Sinai andDir. of Technology and Innovations\, NYEE;Chairman & Founder\, Eyenovia\, Inc. \n \n \n \n \n \n Topic: New Smart Micro dose Technology for Topical Ophthalmic Delivery-On Earth and in Space/Zero Gravity. \nDr. Ianchulev is a Harvard-trained physician executive\, ophthalmic surgeon\, inventor and serial entrepreneur\, whose work has transformed the ophthalmic field. He is behind many breakthrough innovations: Lucentis (Genentech)\, ORA(Alcon)\, iStent (Iantrek Inc)\, MilOOP (Zeiss)\, Robotic surgery (NEEI) and Optejet (Eyenovia). \n \n \n \n \n \n Follow\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Richard B Rosen\, MDRetina Chief at New York Eye & Ear Infirmary of the Mount Sinai \n \n \n \n \n \n Topic: Robotic Assisted Surgery in Modern Retina. \nDr. Rosen is Distinguished Professor of Ophthalmology\, Vice Chair of Research\, and Retina Chief at the New York Eye and Ear Infirmary of the Mount Sinai. He is a vitreoretinal surgeon\, educator\, and inventor with contributions in ocular imaging and surgical devices.\n \n \n \n \n \n Follow\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Cherry Wan\, PhDSenior Director atClearside Bio \n  \n  \n \n \n \n \n \n Topic: The Superachoroidal Space and Superachoroidal Drug Delivery. \nDr. Wan is the senior director of engineering at Clearside Biomedical. She has held multiple engineering leadership positions in MedTech and pharmaceutical companies. Currently\, Cherry is responsible for the SCS Microinjector\, the proprietary microneedle to administer therapeutics into the suprachoroidal space. \n \n \n \n \n \n Follow\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Tina Guanting Qiu\, MD\, PhD\, Consulting Chief Scientific Medical Officer\, Ophthalmic Therapeutic Innovation \nModerator & Champion \nDr. Qiu is a biopharma physician with 20 years of experience in leading ophthalmic therapeutic frontiers of cell & gene therapy and ocular drug delivery. She has a proven track record of problem solving and creating product value (Lineage Cell\, Inotek Pharma\, Astellas\, GSK). \n \n \n \n \n \n Follow\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Agenda \nWed\, Nov 9:  4:30pm – 6:30pm EST (Online Event) \n\n4:30 – 5:00 General Networking\n5:00 – 6:00 Panelist Forum\n6:00 – 6:30 Meet the Speakers and more networking\n\nAll Zoom links for the Forum and Networking sessions will be sent\nupon registration and again prior to the event. URL:https://www.mdgboston.org/event/ocular-drug-delivery-surgical-advances/ LOCATION:Online CATEGORIES:Featured,Forum,MDG ATTACH;FMTTYPE=image/png:https://www.mdgboston.org/wp-content/uploads/2022/10/Picture4.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20221020T163000 DTEND;TZID=America/New_York:20221020T180000 DTSTAMP:20221022T215713Z CREATED:20221004T165741Z LAST-MODIFIED:20221022T215713Z UID:245859-1666283400-1666288800@www.mdgboston.org SUMMARY:Strategic Patent Protection for Medical Innovations DESCRIPTION:Recordings\n \n \n \n \n \n \n \n \n \n \n \n Full Length\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Fireside Chat with Medical Industry and Patent Experts (Zoom Online)\nHosted by: Medical Development Group Boston \nYour business’s value and long-term success may well hinge on protecting your innovations through patents. Do you have a plan for securing your innovations through patents? Do you know the timing requirements for seeking patent protection? Do you want to strengthen your company’s competitive advantage? \nWe invite you to join an interactive panel discussion with Mary Lou Wakimura and Larry Cogswell\, Ph.D.\, U.S. patent attorneys and Principals at Hamilton Brook Smith Reynolds\, panelists Renee Masi from BioStar Ventures and Chase Coffman from Elektrofi\, who have worked to wrestle with these issues. The panelists will have a fireside chat to illustrate strategies used to protect and enforce patent rights\, including: \n\nIdentifying your company’s valuable intellectual property\nUsing patents to protect innovation\nAvoiding pitfalls that can forfeit your patent rights\nDetermining the best timing to protect your innovation\nUnderstanding the value of your patent to help grow your business\, raise funding\, and partner with other medical companies\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Renee Masi\, MBA\n Managing Director\, BioStar Ventures \n Renee Masi has more than 25 years of experience in the venture capital industry where she focused most recently on life science investing. Ms. Masi currently serves on the boards of Autonomix\, CardiacMD\, and SynergEyes. Prior to joining BioStar Ventures\, Ms. Masi was a Partner with Windward Ventures\, a firm focused on southern California early-stage companies\, where she was responsible for the firm’s life science investing strategy. Ms. Masi was an advisor to Ventures Medical\, a seed stage fund affiliated with the Texas Medical Center. In 1990\, Ms. Masi opened the Boston office for Technology Funding\, a $250 million venture capital fund based in San Mateo\, California. She began her career as an investment banker in the healthcare finance group of Merrill Lynch. In addition to holding a BA from Stanford University and an MBA from The Wharton School of Business\, Ms. Masi is also a member of the Board of Councilors for the USC Graduate School of Social Work.\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Chase Coffman\, PhD\n CEO & Co-Founder\, Elektrofi \n Chase Coffman is Co-founder of Elektrofi\, a Boston-based biotech that is working to enhance access to critical biologic medicines through a novel delivery platform. He holds a Ph.D. from MIT in Aeronautics and Astronautics and was formerly a Space Technology Research Fellow at the National Aeronautics and Space Administration (NASA).\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Mary Lou Wakimura\, JD\n Principal\, Hamilton Brook Smith Reynolds \n For over 30 years\, Mary Lou has assisted clients with patent preparation and prosecution\, copyright registration\, and portfolio management. Mary Lou’s approach with clients is to learn their business goals and then strengthen their positions in their industry by developing strong intellectual property strategies. She has particular experience with computer-related technologies and systems relating to imaging\, video applications\, mobile applications\, machine learning\, various platforms (cloud based\, SaaS)\, virtual currency\, solid modeling\, simulations and mathematical models.\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Lawrence Cogswell\, PhD MODERATOR\n Principal\, Hamilton Brook Smith Reynolds \n \nLarry is an experienced IP litigator\, Ph.D. scientist\, patent prosecutor\, and trusted counselor in strategic IP matters\, such as IP due diligence. Larry is a former judicial clerk to the United States Court of Appeals for the Federal Circuit.  He is also a graduate of Yale Law School\, Harvard University\, and Duke University. As an IP litigator\, Larry represents clients in patent\, copyright\, trademark and trade secret cases.  Clients rely on Larry’s integrated understanding of the legal and technical aspects of the case\, which enables a thorough vetting of the issues and cost-effective analysis and delivery of solid\, practical advice. \n\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Agenda\nOct 20\, 2022 (Zoom Online)\n4:30 pm – 6:00 pm EDT (including Q&A)\nAbout Hamilton\, Brook\, Smith & Reynolds\, P.C. \nHamilton Brook Smith Reynolds is an internationally renowned law firm devoted to the practice of intellectual property law. The firm specializes in patents\, trademarks\, intellectual property litigation\, post-grant proceedings\, copyrights\, licensing\, due diligence\, opinions\, trade secrets\, and intellectual property counseling. The firm’s legal staff provides comprehensive intellectual property expertise in a wide range of technical areas such as biotechnology\, chemistry\, computer hardware and software\, telecommunications\, medical devices\, pharmaceuticals\, physics\, optics\, nanotechnology\, and electrical\, chemical\, and mechanical engineering. \nThe Zoom Link will be provided upon registration and sent again on the morning of the event – we encourage you to pre-sign into Zoom when you get the link to ensure there are no issues. URL:https://www.mdgboston.org/event/strategic-patent-protection-for-medical-innovations/ LOCATION:Online CATEGORIES:Forum,MDG ATTACH;FMTTYPE=image/jpeg:https://www.mdgboston.org/wp-content/uploads/2022/10/MDG-10.20.22-Event-Promotion-Image_Small-scaled.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20220921T163000 DTEND;TZID=America/New_York:20220921T183000 DTSTAMP:20221023T192642Z CREATED:20220907T150805Z LAST-MODIFIED:20221023T192642Z UID:245419-1663777800-1663785000@www.mdgboston.org SUMMARY:Advances in Diabetes Care Using Consumer Friendly Wearables & Mobile Phone Apps DESCRIPTION:Recordings\n\n \n \n \n \n \n \n \n \n \n \n \n Full Length\n \n \n \n \n \n \n \n \n \n \n \n \n Highlights Preview\n \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Abstract\n\nMedtech product design is being transformed by consumer friendly wearable medical devices and smartphone Apps. An outstanding example is diabetes mellitus\, a devastating disease which can lead to\, if not controlled\, multiple consequences such as blindness\, kidney failure\, amputation\, and premature death. Approximately 7.4 million diabetics in the US rely on insulin.\n.\nThese sophisticated devices and software make possible continuous blood sugar monitoring\, are readily self-managed by patients\, and can encourage healthful behavior changes. Insurance companies and investment groups now understand the tremendous cost savings that can be accrued from the tighter control of blood glucose levels. \n.\nOur speakers will show us three different ways in which technology is helping patients with diabetes control their glucose levels and thus decrease their chances of having devastating complications.\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Doug Lawrence\, MBA \n CEO of Hygieia and Co-Founder of HydroSpire \n Mr. Lawrence is an experienced Fortune 500 executive and startup CEO.  He has developed and launched single use medical devices and diagnostics products serving clinicians managing diabetes\, ophthalmology critical care and infusion therapy markets and patients around the world. He resides in Framingham\, MA. \nTopic: He will discuss d-Nav\, Hygieia’s mobile app that is the first FDA-cleared system that autonomously calculates and adjusts the dose of insulin that a patient with Type 2 diabetes mellitus should inject. \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Tom Bishop\n CTO (Sensor) for PKvitality SaS \n Mr Bishop has 35 years of experience leading R&D departments\, developing innovative and non-invasive continuous glucose monitoring products. He is a renowned diabetes expert\, highly specialized in CGM\, and is in charge of sensor development and clinical.\n\n.\nTopic: He will discuss K’Watch from PKvitality\, which is a wrist watch that continuously monitors glucose levels and alerts users of highs and lows.\n\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Jason O’Connor\n VP of Product at Insulet Corporation \n Mr. O’Connor is an engineer turned product leader\, who is responsible for ensuring that Insulet’s product portfolio has a customer centric product focus. He led the design of Omnipod 5\, Insulet’s flagship Automated Insulin Delivery system.\n   \nTopic: How advancements in consumer medical devices and interoperability have led to groundbreaking technology like Insulet’s Omnipod 5.\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Breanna Everett\, MD\, MBA MODERATOR\n CEO & Co-Founder\, Orpyx Medical Technologies Inc. & Kinetyx Sciences Inc. \n Dr. Everett is a medical doctor who completed residency training in plastic and reconstructive surgery at the University of Calgary. Seeing the burden that diabetic foot complications pose on both patients and the healthcare system\, she founded Orpyx\, a digital therapeutic company that has a comprehensive turnkey solution to extend health span. \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n David N. Nussbaum\, DPM\, DABFAS. EVENT CHAMPION\n Software Engineer\, Board Certified Podiatrist\, Python Institute Certified Programmer (PCEP) \n Dr. Nussbaum is a board-certified podiatric physician with extensive patient care experience as well as Python language and software engineering training. He is endeavoring to pivot from clinical care to working with a healthcare company in a role that would allow him to utilize his extensive clinical experience to maximize the client usage experience and function as a bridge between the clients and the programming team by applying his familiarity with both the clinical and technical terminology. \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Agenda\nSept 21\, 2022: 4:30 pm – 6:30 pm EDT\n\n4:30 – 5:00 General Networking\n5:00 – 6:00 Panelist Forum Presentations / Q&A\n6:00 – 6:30+ Meet the Speakers & More Networking\n\nWe will send Zoom Links prior to the event URL:https://www.mdgboston.org/event/advances-in-diabetes-care-using-consumer-friendly-wearables-mobile-phone-apps/ LOCATION:Online CATEGORIES:Featured,MDG ATTACH;FMTTYPE=image/jpeg:https://www.mdgboston.org/wp-content/uploads/2022/09/Graphic-for-2022-Sept-21-Diabetes-Forum-scaled.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20220914T080000 DTEND;TZID=America/New_York:20221026T170000 DTSTAMP:20220919T133624Z CREATED:20220919T133624Z LAST-MODIFIED:20220919T133624Z UID:245546-1663142400-1666803600@www.mdgboston.org SUMMARY:TEST for tickets DESCRIPTION: URL:https://www.mdgboston.org/event/test-for-tickets/ LOCATION:Online END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20220728T130000 DTEND;TZID=America/New_York:20220728T140000 DTSTAMP:20220720T185506Z CREATED:20220720T185506Z LAST-MODIFIED:20220720T185506Z UID:245129-1659013200-1659016800@www.mdgboston.org SUMMARY:Considerations for Building Your Own Cloud Device: Regulations\, Privacy & Cybersecurity DESCRIPTION:Medical devices are becoming increasingly cloud-connected. What used to be a technology only deployed by the largest\, most well-funded companies is now becoming a core requirement of most medical device startups. Developing cloud solutions can be a risky endeavor when considering privacy\, security and regulation challenges. \nRegister for this free webinar presented by Abbas Dhilawala\, CTO of Galen Data\, who will describe these challenges and provide considerations that are critical for success. For companies developing devices with a cloud dependency\, investors in medical device companies\, or those who have a general interest in medical device innovation\, please join us for this informative webinar and Q&A session. \nRegister here: GreenLight Guru URL:https://www.mdgboston.org/event/considerations-for-building-your-own-cloud-device-regulations-privacy-cybersecurity/ LOCATION:Online CATEGORIES:Affiliate,Featured ATTACH;FMTTYPE=image/png:https://www.mdgboston.org/wp-content/uploads/2022/07/Greenlight-Guru-2.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20220713T120000 DTEND;TZID=America/New_York:20220713T130000 DTSTAMP:20220720T205513Z CREATED:20220622T170554Z LAST-MODIFIED:20220720T205513Z UID:244633-1657713600-1657717200@www.mdgboston.org SUMMARY:The Distributed Medical Device: A Game-Changing Architecture for Medical Devices DESCRIPTION:Recording\n\n \n \n \n \n \n \n \n \n \n \n \n Full Length\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Abstract\n\nWe are rapidly approaching a world in which every medical device will be a part of the Internet of Medical Things (IoMT). Transferring the processing and data storage to the cloud rather than on the edge hardware\, opens up a new horizon in the fields of healthcare and life sciences.\n.\nReduced operational costs\, centralized device management\, collaboration\, enhanced privacy and data processing\, are just a few of the benefits of leveraging cloud for healthcare. However\, nothing comes without a tradeoff; in this case there are challenges relating to cloud change management among others.\n.\nThis Forum updates you on developing and managing key biomedical\, business\, and IT aspects.\n.\n\nIn this webinar you will learn: \n\nWhat is a distributed medical device is and the role of the cloud in the architecture\nWhy this architecture is a game-changer in terms of device costs\, overall quality\, and product innovation speed\nNew patient outcomes enabled by distributed medical devices\nChallenges and limitations of Distributed Medical Devices\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n SPEAKER\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Itai Weissman\n VP Product at BioT \n Itai Weissman is VP Product at BioT. Previously he was VP Product at an Israeli Nasdaq-traded company specializing in SaaS solutions for Cyber analytics and communications. \nBioT specializes in providing a no-code medical grade and fully secured cloud-based platform for building distributed medical devices in record time – instead of years\, in just one day. \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n You will receive an automatic email with the Zoom Meeting link upon registration.  \nPLEASE CHECK YOUR SPAM FOLDER \nWe will resend the Zoom link on the day of the event. URL:https://www.mdgboston.org/event/the-distributed-medical-device-a-game-changing-architecture-for-medical-devices/ LOCATION:Online CATEGORIES:Affiliate,Featured,MDG ATTACH;FMTTYPE=image/png:https://www.mdgboston.org/wp-content/uploads/2022/06/MEDTECH-LINKEDIN.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20220629T163000 DTEND;TZID=America/New_York:20220629T183000 DTSTAMP:20220724T173240Z CREATED:20220616T154555Z LAST-MODIFIED:20220724T173240Z UID:244285-1656520200-1656527400@www.mdgboston.org SUMMARY:Finding Resources and Making Your Best Path Through End of Life DESCRIPTION:Recordings\n\n \n \n \n \n \n \n \n \n \n \n \n Full Length\n \n \n \n \n \n \n \n \n \n \n \n \n \nHighlights Preview – To Be Added\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Abstract\n\nBe it a friend\, loved one\, or yourself it is most people will have to deal with an end-of-life care situation. This may arrive in the form of terminal illness such as severe cancer or ALS but also may come simply with advanced age. Yet despite how common this is many\, if not most\, are caught completely unprepared and don’t even know where to begin in handling these complex situations.\n. \nThis forum will aim to provide perspective in how to deal with this from technological\, caregiving\, and financial angles. It is our goal that people come away from this event with a greater appreciation for the physical and personal needs and how to meet them during this time.\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Ron Hoffman\n Founder/Executive Director of Compassionate Care ALS \n Mr. Ron Hoffman co-founded the Gordon T. Heald ALS fund along with Elizabeth Heald following Gordon’s death in 1998. This led to the creation of the nonprofit organization Compassionate Care ALS. He has worked with thousands of individuals\, families\, and communities living with Lou Gehrig’s Disease in the US and around the world. Ron’s work helps examine the myriad of choices that people confront including the process of death and dying as together they create space for dialogue around their question and decisions. \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Cory Kidd\, PhD\n Founder and CEO Catalia Health \n     \nDr. Kidd is an experienced entrepreneur who has been working in healthcare technology for more than two decades. He is the founder and CEO of Catalia Health\, a chronic disease care management company that provides an effective AI-powered solution to keep patients on therapy and improve outcomes. The focus of his work has been applying innovative technologies towards solving large-scale healthcare challenges.\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Janice Henderson\, CFP\n Chair/CEO\, Law and Associates \n \nMs. Henderson has been a Certified Financial Planner since 1988\, joining Law & Associates\, Inc. in 1994. She took ownership of the firm in 2016 and currently serves as Chair/CEO (Law) and Branch Manager (RJFS). Having personally experienced a divorce as well as the loss of both parents and two sisters\, Janice has an intimate understanding of the complications that these life changes bring. \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Geoff Moodie\, PhD - Moderator & Event Champion \n Director\, Biocompatibility Eurofins; Board of Directors\, MDG Boston \n Dr. Moodie has over twenty years of experience in the medical device industry\, working in combination product development\, performing safety evaluations for regulatory submissions\, and leading teams.  He has been active in MDG since 2016.  For this forum he is moderating with personal experience as someone who lost a family member to terminal disease. \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Agenda\nJune 29\, 2022: 4:30 pm – 6:30 pm EDT\n\n4:30 – 5:00 General Networking\n5:00 – 6:00 Panelist Forum\n6:00 – 6:30+ Meet the Speakers & More Networking\n\nWe will send Zoom Links prior to the event URL:https://www.mdgboston.org/event/finding-resources-and-making-your-best-path-through-end-of-life/ LOCATION:Online CATEGORIES:Featured,MDG ATTACH;FMTTYPE=image/jpeg:https://www.mdgboston.org/wp-content/uploads/2022/06/Couple-Hugging-update-2.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20220628T130000 DTEND;TZID=America/New_York:20220628T143000 DTSTAMP:20220616T154720Z CREATED:20220610T200429Z LAST-MODIFIED:20220616T154720Z UID:244268-1656421200-1656426600@www.mdgboston.org SUMMARY:AI and Medical Devices – Finding the Sweet Spot DESCRIPTION:AI is coming to healthcare and will change medical devices and your plans. Are you ready? \n Victoria BC (June 10\, 2022) StarFish Medical announces Moshe Safran and Dr. Phillip Alvelda\, two medtech entrepreneurs deeply entrenched in medical device AI\, share their insights in AI and Medical Devices – Finding the Sweet Spot in a 90 minute live Medical Device Playbook webinar on June 28\, 2022.  \nMoshe Safran\, CEO of RSIP Vision USA presents: “Adding value to medical devices with AI – case studies from echocardiology and orthopedics“. \nDr. Phillip Alvelda\, CEO & Chairman | Medio Labs + Brainworks presents: “Novel Health-tech Applications Enabled by Artificial Intelligence”. \nAttendees will learn: \n\n Tips & best practices for medical AI implementation\n Choosing the right application for a value add\n How AI is reducing healthcare complexity\, overhead and expenses\n Shifts from health crisis treatment towards preventive care\n Challenges & lessons learned\n\nCase Studies Include: \n\nAutomated and ambient vital signs measurement\nRevolution in molecular diagnostics\n\nScott Phillips\, Medical Device Playbook and StarFish Medical Founder\, hosts and moderates live audience Q&A with presenters. \n Webinar Date and Time: Tuesday\, June 28\, 2022 –  1:00pm EDT / 10:00am PDT URL:https://www.mdgboston.org/event/ai-and-medical-devices-finding-the-sweet-spot/ LOCATION:Online CATEGORIES:Affiliate ATTACH;FMTTYPE=image/png:https://www.mdgboston.org/wp-content/uploads/2022/06/Starfish-AI-event.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20220615T120000 DTEND;TZID=America/New_York:20220615T130000 DTSTAMP:20220705T233416Z CREATED:20220521T135239Z LAST-MODIFIED:20220705T233416Z UID:243914-1655294400-1655298000@www.mdgboston.org SUMMARY:Market Volatility\, Inflation\, & Taxes: Strategies to Protect Your Assets DESCRIPTION:Recording\n \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Abstract\n\n5 key topics of discussion\n\nWhy is inflation so high?\nRecession-What will happen this time.\nAsset Protection vs Asset Preservation.\nTaxes and your retirement accounts.\nWhat to do with your money today.\n\nInflation has shown up in our everyday lives from gasoline to groceries. How did we get here and is there an end in sight?\n   \nThe federal reserve is attempting to curb the constant rise of prices\, but will they be successful?\n   \nMarket volatility is here to stay\, so what strategy will work to hedge the risks before us. Taxes are on the rise and our retirement plans are a potential tax time bomb in the future.\n    \nPlease come and join us on these and other informative topics of discussion for you and your money.\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Vincent Serratore\n Senior Managing Director\, Heritage Wealth Management \n    \n\n\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n June 15\, 2022: 12 – 1 EDT\nThe Zoom link will be sent prior to the event URL:https://www.mdgboston.org/event/market-volatility-inflation-taxes-strategies-to-protect-your-assets/ LOCATION:Online CATEGORIES:Featured,Forum ATTACH;FMTTYPE=image/jpeg:https://www.mdgboston.org/wp-content/uploads/2022/05/2022_Jun15-Forum_Graphic_Inflation-4.jpeg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20220601T163000 DTEND;TZID=America/New_York:20220601T183000 DTSTAMP:20220721T154529Z CREATED:20220502T143150Z LAST-MODIFIED:20220721T154529Z UID:243637-1654101000-1654108200@www.mdgboston.org SUMMARY:Innovation in Orthopedics DESCRIPTION:Recordings\n\n \n \n \n \n \n \n \n \n \n \n \n Full Length\n \n \n \n \n \n \n \n \n \n \n \n \n Highlights Preview\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Abstract\nIndustry leading speakers will address the current dynamics in the orthopedic sector\, addressing both new technologies and the impact of surgical advances over the past 2 years. \n     \nJoin us to discuss the exciting innovations and business opportunities in this space!\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Andrea Light\, MBA\n Sr. Director\, US Knee Commercial Marketing\, Smith & Nephew \n Ms. Light has extensive experience in the marketing of orthopedic devices. Prior to Smith and Nephew\, she spent 19 years at Johnson & Johnson’s DePuy Synthes with her last role as Director\, US Marketing. She received her degree in mechanical engineering from Union College and her MBA from Babson College.\n\n\nTopic: The dynamics in the knee implant market and major trends in the orthopedic space.\n\n\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n James Paiva\, MS\n VP\, Marketing Conformis \n    \n\nMr. Paiva leads the marketing organization at Conformis\, Inc. which uses patient data to design and produce personalized joint replacements\, for a custom form and fit.  Previously\, he was Senior Director of Global Marketing at Johnson & Johnson.  He holds a degree in biology from the University of Rhode Island and an MS in biomedical engineering from Brown University.\n\nTopic: Perspectives on the custom orthopedic implant market and dynamics\, especially given the shifts in the market and patient preference post-pandemic.\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Brennan Marilla\n Chief Commercial & Operating Officer\, Ossio \n Mr. Marilla has a successful record of driving growth and transformation. He most recently served as Chief Commercial Officer for Surgical Specialties Corp. Prior\, he was VP & GM of Covidien’s $650M Endovascular business and VP\, Sales and Marketing for their $1B+ Peripheral Vascular sector. Before Covidien\, he was VP\, US Sales and Director\, for Medtronic’s Global Marketing for their aortic stent graft business. He received his bachelors of science in business management from North Carolina State University.\n\nTopic: Innovation in bone healing and a new category of “Bio-Integrative” implants \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Ilsa Webeck\, MBA\n Managing Director & Founder\, MedTech Strategies \n Ms. Webeck is Managing Director and Founder of MedTech Strategies\, with work experiences at Biogen\, Heartware\, and DePuy Spine (a J&J company). She is also on the current board of directors of MDG Boston. She has a degree in biology from Dartmouth College and an MBA from the Tuck School of Business.\n\n\nTopic: Overview of the orthopedic market\, looking at shifts in care and treatment as adjustments have been made to accommodate product and surgical demand challenges.\n\n\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Agenda\nJune 1\, 2022: 4:30 pm – 6:30 pm EDT\n\n4:30 – 5:00 General Networking\n5:00 – 6:00 Panelist Forum\n6:00 – 6:30+ Meet the Speakers & More Networking\n\nWe will send Zoom Links prior to the event URL:https://www.mdgboston.org/event/the-orthopedic-device-value-chain/ LOCATION:Online CATEGORIES:Featured,MDG ATTACH;FMTTYPE=image/jpeg:https://www.mdgboston.org/wp-content/uploads/2022/05/Picture8.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20220525T163000 DTEND;TZID=America/New_York:20220525T183000 DTSTAMP:20220609T042037Z CREATED:20220510T025843Z LAST-MODIFIED:20220609T042037Z UID:243647-1653496200-1653503400@www.mdgboston.org SUMMARY:Money and Medical Devices: Taking the First Steps Towards Funding Your Medical Startup DESCRIPTION:Recordings\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n Full Length Recording\n \n \n \n \n \n \n \n \n \n \n \n \n Highlights Preview\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Abstract\n\nFinding your first investment funding requires building connections to the innovation ecosystem and learning how to talk about your idea as a company. Turning an idea into a product isn’t easy in any industry\, but in the medical device industry innovators face challenges barely imaginable to innovators in other sectors. \n\nHow does anybody make it work? Join this MDG program to learn how to take your first steps on the way to turning your medical device idea into a product. \n\nThis MDG program will:\n\nIntroduce you to some of the experts shepherding innovators into the innovation ecosystem\nTeach you best practices for approaching and becoming involved in the innovation ecosystem\nProvide an introduction to technology incubators\, university-based innovation centers\, corporate partner innovation/development centers\, and angel investors\nHelp you to begin building your support network for seeking investments for your idea\nHelp you determine the first step for turning your idea into a plan and then a product\nPrepare medical device innovators to identify the steps to grow an idea into a real plan and product that interests investors. \n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Mary Ann Picard\, MS\n Director of Operations at M2D2 @ UMass - An Incubator for Med Device & Biotech start-up cos. \n    \nMs. Picard has ~20 years of business development experience establishing and maintaining long-term corporate relationships\, including project management and funding. At M2D2\, a joint project between UMass Lowell and UMass Medical School to advance the entrepreneurial business ecosystem in Massachusetts\, she fosters interactions among entrepreneurs\, inventors\, scientists\, students\, industry\, investors\, state agencies\, and others.\n\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Shayan Bhattacharyya\, MBA\n Venture Partner\, Strategic Advisor\, Healthcare Executive \n    \n\n\n   \nMr. Bhattacharyy has deep operational expertise across the healthcare ecosystem and currently serves as a Venture Partner at Zoic Capital where he supports investment and advising startups on commercial and acquisition strategy. He has held leadership positions at United Health Group\, the Blue Cross Blue Shield spin-out\, Blue Health Intelligence\, as well as Medtronic and Boston Scientific.\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Wendy Slone\, PhD\n CEO/Founder of bTECH \n      \n  \n  \nDr. Slone invented the Halycon SMART Patch\, reflecting her experience in nanotechnology and in developing biopolymers for biomedical applications in treatment of chronic non-healing wounds as with diabetic foot ulcers. She has led bTECH’s participation in the REDIZone Incubator and Commercialization Program at the Northeast Ohio Medical University\, gBETA MedTech for Black Founder’s Accelerator Program and much more.\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Jeff Champagne\, MBA - MODERATOR\n Medical Technology and Life Science Product Development\, Business Development\, Product Marketing Executive\, Creative Director\, Angel Investor \n   \nMr. Champagne’s background in R&D and Marketing underlies his product development consulting work in Life Sciences\, which crosses over multiple industries\, including Biotech\, Medical Device\, Energy\, Advanced Materials\, Specialty Chemistry\, Food & Beverage\, and Consumer Products. He is able to help guide clients in their efforts to commercialize new products and launch startup companies.\n\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Kristofer Munroe\, JD - CO-CHAMPION\n Market Access Strategy and Insight \n \n \n \n \nMr. Munroe has nearly 20 years of experience in advocacy. He works with patients and medical device manufacturers to solve problems related to access to care. He provides expertise in the design of\, implementation of\, and training of personnel in strategies for commercialization\, reimbursement\, and compliant healthcare provider interactions and support services. Through his work at Argenta\, he has supported a range of clients\, from large multinational medical device manufacturers to early-stage innovators. \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Jeff Karg\, MS - CO-CHAMPION\n President\, MDG Boston; Managing Director\, Boston Innovation \n \n \n \n \nMr. Karg’s professional experience encompasses technology development\, entrepreneurship\, and business leadership. Successful in technology creation and product development in both startup and corporate environments\, he has been through multiple development and funding cycles and is expert in navigating complex projects with large teams. \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Agenda\nMay 25\, 2022: 4:30 pm – 6:30 pm EDT\n\n4:30 – 5:00 General Networking\n5:00 – 6:00 Panelist Forum\n6:00 – 6:30+ Meet the Speakers & More Networking\n\nAll Zoom links for the Forum and Networking sessionswill be sent upon registration and again just prior to the event. URL:https://www.mdgboston.org/event/money-and-medical-devices-taking-the-first-steps-towards-funding-your-medical-startup/ LOCATION:Online CATEGORIES:Featured,MDG ATTACH;FMTTYPE=image/jpeg:https://www.mdgboston.org/wp-content/uploads/2022/05/Picture2.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20220525T130000 DTEND;TZID=America/New_York:20220525T143000 DTSTAMP:20220610T033447Z CREATED:20220519T153309Z LAST-MODIFIED:20220610T033447Z UID:243891-1653483600-1653489000@www.mdgboston.org SUMMARY:Bootstrapping to a $2 Billion Exit – The Baylis Medical Story DESCRIPTION:Event Details: \nBootstrapping to a $2 Billion Exit – The Baylis Medical Story \n May 25\, 2022 | 10:00-11:30am PDT \nFrank Baylis and Kris Shah share their remarkable journey transforming and bootstrapping Baylis Medical Company to a $2 Billion exit and acquisition by Boston Scientific in October 2021. \nScott Phillips interviews Frank Baylis and Kris Shah\, then moderates live audience Q&A in a special 90-minute webinar event. \nTopics include: \n– Secret to Long Partnerships\n– Bootstrapping from 2 to 1000+ Employees\n– From Distributor to Manufacturer\n– Managing Mistakes\n– Adding a Board\n– Increasing Exit Value\n– Seeking an Exit\n– The Future \nRegistration URL:https://www.mdgboston.org/event/bootstrapping-to-a-2-billion-exit-the-baylis-medical-story/ LOCATION:Online CATEGORIES:Affiliate ATTACH;FMTTYPE=image/png:https://www.mdgboston.org/wp-content/uploads/2022/05/Starfish-Bootstrapping.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20220427T163000 DTEND;TZID=America/New_York:20220427T183000 DTSTAMP:20220706T154911Z CREATED:20220406T173431Z LAST-MODIFIED:20220706T154911Z UID:243003-1651077000-1651084200@www.mdgboston.org SUMMARY:Advances in Cardiology - Interventional Technology in 2022 DESCRIPTION:Recordings\n\n \n \n \n \n \n \n \n \n \n \n \n Full Length\n \n \n \n \n \n \n \n \n \n \n \n \n Highlights Preview\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Abstract\nHeart disease remains the number one killer of men and women in the US and globally. Unexpectedly\, COVID-19 has emerged as a major new cause of cardiac damage. In this Forum\, you will hear from leaders in interventional cardiology who are developing technologies to overcome challenges in treating cardiovascular patients. These include imaging\, drug delivery\, biomarkers for COVID-19 related clot formation\, and structural heart disease. Hear and meet these leaders in CV disease diagnosis and treatment.\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Mazen Albaghdadi\, MD\, MSc\n Physician Innovation Fellow at Edwards Lifesciences \n    \n         \nDr. Albaghdadi is an accomplished physician-scientist with a background in engineering and pre-clinical testing\, and device innovation. He has developed many cardiovascular technologies including intravascular imaging modalities\, macro- and nano-drug delivery systems\, biomarkers in COVID19-related thrombosis\, and structural heart disease.\n\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Stuart T. Higano\, MD\, FACC\, FSCAI\n Medical Director\, Heart LifeLine Alliance\, Missouri Baptist Medical Center\, Saint Louis\, Missouri \n    \nDr. Higano is Medical Director of Heart LifeLine Alliance\, formed in 2008 in partnership with rural hospitals\, medical helicopter and ambulance services to provide emergency services for rapid evaluation and treatment of heart attack patients. He will speak about how new technologies are helping to overcome challenges in interventional cardiology.\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Marty Sklar\, MSME\, BSME\n Business Development\, Electrophysiology Frontiers\, Co-Founder of MDG Boston \n      \nMr. Sklar is an accomplished leader\, inventor\, consultant and engineer. In 2013\, he founded Ablacor Medical Corporation (now part of Electrophysiology Frontiers) to develop remote controlled instruments for minimally invasive medical applications. He was a co-founder and first president of MDG Boston.\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Lisa Sasso\, MBA\, PCC\, CPCC\n Executive Coach & President\, Medical Development Partners; Former President\, MDG Boston MODERATOR \n Ms. Sasso was President & CEO of Radi Medical Systems for 6 years. She grew revenue from $0 to $28M and was recognized and ranked #28 out of 100 Women Led Businesses in MA in 2004. She is President of Medical Development Partners and offers her experiences as an executive coach.\n\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Geoff Moodie\, PhD\n Director\, Biocompatibility\, Eurofins; Board of Directors and VP of Programming for MDG Boston \n \nDr. Moodie a goal driven scientist with an expertise in absorbable materials and combination products for medical device and drug delivery applications. His experience includes preclinical study development\, troubleshooting\, and monitoring\, as well as budgeting\, timelines and resource allocation. \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Hamsini Sundararaman\n Biomedical Engineer; Event Organizer for Program Central\, MDG Boston \n \nMs. Sundararaman is a recent graduate of Northeastern University with a Master’s Degree in Bioengineering with a specialization in medical device design and bio-imaging.       \n  \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Agenda\nApril 27\, 2022: 4:30 pm – 6:30 pm EDT\n\n4:30 – 5:00 General Networking\n5:00 – 6:00 Panelist Forum\n6:00 – 6:30+ Meet the Speakers & More Networking\n\nAll Zoom links for the Forum and Networking sessionswill be sent upon registration and again just prior to the event. URL:https://www.mdgboston.org/event/advances-in-cardiology-interventional-technology-in-2022/ LOCATION:Online CATEGORIES:Featured,MDG ATTACH;FMTTYPE=image/png:https://www.mdgboston.org/wp-content/uploads/2022/04/2022_April-27-Graphic.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20220316T163000 DTEND;TZID=America/New_York:20220316T183000 DTSTAMP:20220430T111832Z CREATED:20220216T165111Z LAST-MODIFIED:20220430T111832Z UID:242179-1647448200-1647455400@www.mdgboston.org SUMMARY:MedTech Leaders Share Insights From Their Product Development Journeys DESCRIPTION:Recordings\n\n \n \n \n \n \n \n \n \n \n \n \n Full Length\n \n\n \n \n \n \n \n \n \n \n \n \n \n Highlights Preview\n \n  \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Abstract\n\nOur Moderator\, Laurin Noel\, VP of Business Development at Sunrise Labs\, will guide a round table discussion on perspectives ranging from start-ups nearing commercialization to large global organizations with game-changing product portfolios.\n    \nSpecific medtech challenges covered include: 1) Improved preservation of donor organs in transport; 2) Treatment of postoperative intestinal blockage; and 3) strategies used to manage complex software development efforts at a global medtech leader.\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Swarna Balasubramaniam\, MD\n CEO\, Founder\, and Surgeon\, Noleus Technologies \n    \nDr. Balasubramaniam is a colon & rectal surgeon and the founder of Noleus Technologies. Noleus is a novel therapeutic medical device that accelerates patient recovery after abdominal surgery operations by treating post-operative ileus (intestinal obstruction).\n\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Efdal Elferri\, MS\n MS R&D Manager\, Abbott \n    \nEfdal Elferri oversees scrum teams of software engineers developing next generation products at Abbott. She is responsible for requirements development throughout the entire product lifecycle across multiple platforms and leads process improvements within the R&D organization. \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Lisa Anderson\, PhD\n CEO\, President & Co-Founder\, Paragonix \n      \nDr. Anderson leads Paragonix\, founded in 2010\, which is developing the Paragonix Sherpa™ Cardiac Transport System\, a novel\, single-use organ preservation device to improve donor organ quality. Her PhD is in Medical Genetics from Cambridge University.\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Laurin Noel\n VP\, Business Development Sunrise Labs\, MODERATOR \n   \nLaurin Noel has spent 20+ years partnering with medical device companies to accelerate product development and bring innovative medical technologies to market.\n\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Andrea Cahill - CO-CHAMPION\n Sr. Systems Engineer\, Boston Scientific; Board of Directors\, MDG Boston \n \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Urvi Kanakaraj\, MS\, CO-CHAMPION\n Software Quality Engineer\, PathAI; Program Central\, MDG Boston \n \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Agenda\nMar 16\, 2022: 4:30 pm – 6:30 pm EDT\n\n4:30 – 5:00 General Networking\n5:00 – 6:00 Panelist Forum\n6:00 – 6:30+ Meet the Speakers & More Networking\n\nAll Zoom links for the Forum and Networking sessionswill be sent upon registration and again just prior to the event. URL:https://www.mdgboston.org/event/medtech-leaders-share-insights-from-their-product-development-journeys/ LOCATION:Online CATEGORIES:Featured,MDG ATTACH;FMTTYPE=image/png:https://www.mdgboston.org/wp-content/uploads/2022/02/2022Mar16_Graphic3Final3.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20220309T163000 DTEND;TZID=America/New_York:20220309T183000 DTSTAMP:20220418T015450Z CREATED:20220119T193521Z LAST-MODIFIED:20220418T015450Z UID:241474-1646843400-1646850600@www.mdgboston.org SUMMARY:CEOs Discuss Innovations in Women’s Health That Address Major Unmet Needs DESCRIPTION:Recordings\n\n \n \n \n \n \n \n \n \n \n \n \n Full Length\n \n \n \n \n \n \n \n \n \n \n \n \n Highlights Preview\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Abstract\nOur Moderator\, Monica Mallampalli\, CEO of the Institute for Women’s Health Strategies\, will provide an overview on diagnostic and therapeutic market opportunities (the global market for women’s health is expected to reach $41B by 2027).\n    \nOur panelists will describe innovative solutions for major unmet needs including early detection of ovarian cancer\, pelvic organ prolapse\, and use of thermoregulatory science to ameliorate symptoms of menopause.\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Monica Mallampalli\, PhD \n CEO\, Institute of Women’s Health Strategies - MODERATOR \n \n\n\n    \nDr. Mallampalli is a biomedical scientist\, thought leader\, subject matter expert and a women’s health advocate. In her CEO role\, provides consulting services to non-profit and for-profit sectors. She previously served as the VP of Scientific Affairs at the Society for Women’s Health Research (SWHR) where she was the chief architect on key programs related to sex-based biology with a focus on women’s health.\n \nShe will provide an overview of the state of women’s health and focus on conditions that are still under-recognized and under treated\, but have the potential for development of new diagnostics and therapeutics.\n\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Deborah Garner\, MBA\n Co-CEO FEMSelect \n    \n\n     \nMs. Garner has over 20 years of experience in commercializing drugs\, devices and healthcare information technology. Before becoming Co-CEO of FEMselect\, a women’s health medical device company\, she held a variety of brand management and sales management roles in the US & Global organizations. She received her MBA from The Wharton School.\n                                          \nShe will provide an overview of FEMSelect’s product\, EnPlace\, a minimally invasive approach to Pelvic Organ Prolapse (POP) repair procedures\, that can be implanted in a 30 minute procedure. \n\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Marina Katayeva\, M. Arch.\n Co-Founder & CEO at Levi Diagnostics; President of Emitech\, its parent company \n Ms. Katayeva works on developing innovative concepts in the fields of nanotechnology and advanced optoelectronic materials. Levi Diagnostics\, Inc.\, focuses specifically on biosensing and medical diagnostics\, currently working to develop rapid\, accurate\, portable devices for viral diagnostics and diagnostics of women’s diseases.\n                              \nShe will describe why diagnostic tests using menstrual blood are proving exceptionally useful indicators of physiology and disease. \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Debbie Dickinson\, Esq\n Co-Founder & CEO\, Thermaband \n \nMs. Dickinson is an experienced Harvard Law benefits attorney\, Wharton Business School alumna and Lecturer\, as well as a serial entrepreneur. Her expertise includes wearable technology\, direct sales and commerce. Debbie envisioned a discreet smart tech wearable to provide thermal relief for hot flashes that utilized digital health data and founded Thermaband\, Inc. with her daughter. Working with Yale scientists\, physicians\, engineers and a highly involved community of women\, they developed the Zone\, a smart temperature regulating wearable. \n\nShe will describe the development of the Zone.\n\n\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Jerrold M. Shapiro\, Ph.D./Bioengineering \n President\, Floelle Inc. - EVENT CHAMPION \n Dr. Shapiro is co-founder\, co-inventor\, and President of Floelle Inc\, a medical device company developing a nonsurgical treatment for one billion incontinent women. Previously\, he was a Senior medtech executive at Candela Laser\, Optical Micro Systems\, Spectrum Medical Technologies (now Cynosure)\, and Fem-Medical LLC (where he worked with incontinent women for 20 years). \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Agenda\nMar 9\, 2022: 4:30 pm – 6:30 pm EDT\n\n4:30 – 5:00 General Networking\n5:00 – 6:00 Panelist Forum\n6:00 – 6:30+ Meet the Speakers & More Networking\n\nAll Zoom links for the Forum and Networking sessionswill be sent upon registration and again just prior to the event. URL:https://www.mdgboston.org/event/ceos-discuss-current-innovations-in-womens-health/ LOCATION:Online CATEGORIES:Featured,MDG ATTACH;FMTTYPE=image/png:https://www.mdgboston.org/wp-content/uploads/2022/01/2022_Mar9Graphic_Final3.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20220216T163000 DTEND;TZID=America/New_York:20220216T183000 DTSTAMP:20220417T185405Z CREATED:20220119T173206Z LAST-MODIFIED:20220417T185405Z UID:241452-1645029000-1645036200@www.mdgboston.org SUMMARY:CEOs Discuss Product Development Strategies for Startup Funding Success DESCRIPTION:Recordings\n\n \n \n \n \n \n \n \n \n \n \n \n Full Length\n \n \n \n \n \n \n \n \n \n \n \n \n Highlights Preview\n \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Abstract\n\nProduct Development Company CEO’s discuss strategies their clients use to achieve their next round of funding. Our panel will cover planning\, goal setting\, value generation and how they relate to funding.\n    \nFrom an idea through product development to funding through exit\, we will learn how PD firms help startups achieve commercial success.\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Scott Phillips\n CEO\, Starfish Medical \n \n     \nMr. Phillips has grown Starfish into a diverse organization with clients around the world and a 100% focus on medical devices. He is a Chair of the LifeSciences British Columbia BOD\, on the 2022 VIATEC BOD\, Fellow of The Canadian Acad. of Engineering\, winner of the EY Entrepreneur Of The Year™ 2017 Pacific Awards Technology category. His has an Engineering Physics degree from the University of British Columbia. \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Paul DiCesare\n Founder & CEO\, Start LLC \n    \nMr. DiCesare has 30+ years experience in developing medical products. He was Design Director at both Human Factors Industrial Design in New York City as well as Synectic Engineering before opening Start in 1995. Paul is listed as inventor on more than 75 utility patents for medical products. He holds a BS in Industrial Design from the University of Bridgeport.\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Tor Alden\n Global Lead\, HS Design\, A SteriPak Company \n Mr. Alden has built HSD with a human-centered product design approach that combines the disciplines of research\, human factors\, engineering\, design\, marketing\, and manufacturing to meet client’s needs. Initially a designer\, he has developed skill sets in technology management\, business and design strategy that keep him at the forefront of technology development. \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Jeff Karg\n President\, MDG Boston MODERATOR \n   \n\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Agenda\nFeb 16\, 2022: 4:30 pm – 6:30 pm EDT\n\n4:30 – 5:00 General Networking\n5:00 – 6:00 Panelist Forum\n6:00 – 6:30+ Meet the Speakers & More Networking\n\nAll Zoom links for the Forum and Networking sessionswill be sent upon registration and again just prior to the event. URL:https://www.mdgboston.org/event/ceos-discuss-product-development-strategies-for-startup-success/ LOCATION:Online CATEGORIES:Featured,MDG ATTACH;FMTTYPE=image/png:https://www.mdgboston.org/wp-content/uploads/2022/01/2022_Feb16_GraphicFinal2.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20220119T163000 DTEND;TZID=America/New_York:20220119T183000 DTSTAMP:20220418T165156Z CREATED:20211210T201645Z LAST-MODIFIED:20220418T165156Z UID:240755-1642609800-1642617000@www.mdgboston.org SUMMARY:Artificial Intelligence in Medicine - Promise Becoming Practice DESCRIPTION:Recordings\n\n \n \n \n \n \n \n \n \n \n \n \n Full Length\n \n \n \n \n \n \n \n \n \n \n \n \n Highlights Preview\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Abstract\n\nArtificial Intelligence as a concept can be traced to ancient times and arose within many cultures. With the advent of powerful computers\, sophisticated software\, and major advances in engineering\, it is now rapidly changing healthcare and many other industries. A recent market study finds the Global AI Market Size was $62B in 2020 and predicts 40% annual expansion into 2028.\n      \nIn this forum\, you will hear from accomplished professionals within the healthcare industry who are creating AI solutions to advance healthcare. They will share the challenges they have faced in developing and commercializing technologies as well as tools\, approaches\, and best practices found to be the most effective in improving healthcare outcomes.\n\nWho should attend:\n• Clinicians who provide patient diagnosis and treatment\n• Patients who want to learn about AI solutions for early detection of cancer\n• Product developers who will incorporate current and future AI technology in new medical devices\n• Senior management who want to keep their next product line on the leading edge of AI technology.\n     \nHistoric Development                                          Market Size & Predicted Growth\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Monica Jang\, CLP\n Sr. Licensing Manager\, Technology & Innovation Development Office (TIDO)\, Boston Children’s Hospital \n \nMonica is responsible for IP management\, including the Innovation and Digital Health Accelerator. At MIT\, she was a Howard Hughes Medical Institute Liaison for IP licensing.\n\nTopic: Drawing on her experience in technology licensing at BCH and MIT\, Monica will address academic pain points in AI related research and commercialization.\n\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Enrique Hernández\n CEO and Engineer\, Thermy \n    \n\n   \nEnrique is a Mexican bionic engineer and entrepreneur. As an exchange student in Belgium\, he was a finalist of the SLUSH GIA program in Finland. He is a member of the UK’s Royal Academy of Engineering Leaders In Innovation Fellowship.\n      \nTopic: Enrique will describe Thermy’s mission to reduce the number of deaths due to late breast cancer detection.\n\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Jorge Juárez\n Engineer and Machine Learning/Artificial Intelligence Expert\, Thermy \n Jorge is a bionic engineer certified by Stanford University on the design and implementation of deep neural network architectures that he uses to identify patterns of diseases in thermal images. \n      \nTopic:  Jorge will describe the AI project at Thermy and their current efforts to utilize AI for thermal image analysis in breast cancer diagnosis.\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Michael G. Frank\n Digital Ventures Lead\, Memorial Sloan Kettering’s Office of Technology Development \n Michael is a member of the Digital Health team in OTD’s Technology Management and Commercialization group. He spent many years in life sciences and digital venture roles in the biopharmaceutical and management consulting industries.\n      \n\n\n \nTopic: Based on his experience at Pfizer and MSK\, Michael will speak to challenges faced in developing and commercializing AI solutions to advance healthcare.\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Alex Adam\n Principal\, Hamilton Brook Smith Reynolds MODERATOR & EVENT CHAMPION \n Alex is a scientist turned patent attorney who drafts and prosecutes patent applications in the fields of artificial intelligence\, medical devices\, biotechnology\, life sciences\, computer systems\, and many others. He has represented small and medium businesses\, universities\, and start-ups\, learning their business goals and strengthening their positions by developing strong intellectual property strategies.\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Agenda\nJan 19\, 2022: 4:30 pm – 6:30 pm EDT\n\n4:30 – 5:00 General Networking\n5:00 – 6:00 Panelist Forum\n6:00 – 6:30+ Meet the Speakers & More Networking\n\nAll Zoom links for the Forum and Networking sessionswill be sent upon registration and again just prior to the event. URL:https://www.mdgboston.org/event/artificial-intelligence-in-medicine-turning-promise-into-practice/ LOCATION:Online CATEGORIES:Featured,MDG ATTACH;FMTTYPE=image/png:https://www.mdgboston.org/wp-content/uploads/2021/12/2021_Jan19Forum_Graphic.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20211103T163000 DTEND;TZID=America/New_York:20211103T183000 DTSTAMP:20220418T235905Z CREATED:20210528T182434Z LAST-MODIFIED:20220418T235905Z UID:235516-1635957000-1635964200@www.mdgboston.org SUMMARY:Sensor Technology In The Medical Arena\, Now and In The Future DESCRIPTION:Recordings\n \n \n \n \n \n \n \n \n \n \n \n Full Length\n \n \n \n \n \n \n \n \n \n \n \n \n Highlights Preview\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Abstract\nMany recent innovative medical devices are ‘wearables’\, dramatically impacting healthcare as we go about our daily lives. Encompassing both regulated and consumer products\, they increasingly enable health professionals to monitor user/wearer health status 24/7.\nYou will hear about:\n\nHow a startup negotiated the ever-complex processes of fund raising\, medical device design\, and contract manufacturer selection during COVID. \nThe challenges of embedding sensors in wearables using a holistic approach to designing new medical solutions.\nHow testing new technologies is done: what you need to know and what to expect when subjecting your product to the testing process.\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Daniel Weinstein\n CEO & Co-Founder\, Lura Health \n Daniel started Lura Health in 2017. He will describe developing a novel sensor technology worn in the mouth of patients for salivary diagnostics.\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Brenna Schneider\n CEO & Founder\, 99 Degrees \n 99Degrees is a US performance activewear and wearable technology manufacturer based in Lowell\, MA. They integrate sensors\, electronics\, and robotics hardware to rapidly develop\, pilot\, and manufacture tech-integrated apparel.\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Todd Konieczny\n Staff Engineer\, Intertek \n Todd will draw upon his 19 years of medical product compliance testing to describe what you need to know and what to expect.\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Soheil Ashkani-Esfahani\, MD MODERATOR\n CSO of Foot & Ankle Research and Innovation Lab\, Clinical Executive of Orthopaedic Registries\, Mass General\, Harvard Medical School \n Dr. Ashkani-Esfahani is an orthopaedic clinician\, researcher\, innovator\, lecturer\, and entrepreneur\, who has founded several ventures and startups during his career that have mainly focused on improving orthopaedic healthcare. \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Andrew Celentano - EVENT CHAMPION\n Senior Innovation Consultant\, Boston Engineering \n Andrew has 20+ years combined experience in the Technology\, Medical Device\, R&D\, Pharma and Drug Delivery markets. His expertise includes Sales\, Marketing\, Finance\, and Operational Management arenas. \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Agenda\nNov 3\, 2021: 4:30 pm – 6:30 pm EDT \n\n4:30 – 5:00 General Networking\n5:00 – 6:00 Panelist Forum\n6:00 – 6:30+ Meet the Speakers & More Networking\n\nAll Zoom links for attending the Forum and Networking sessionswill be sent to registered individuals prior to the event. URL:https://www.mdgboston.org/event/sensor-technology-in-the-medical-arena-now-and-in-the-future/ LOCATION:Online CATEGORIES:Featured,MDG ATTACH;FMTTYPE=image/jpeg:https://www.mdgboston.org/wp-content/uploads/2021/07/MDG_Event-Featured-Image_Integration-of-Sensors-and-Therapies.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20211020T163000 DTEND;TZID=America/New_York:20211020T183000 DTSTAMP:20220419T001026Z CREATED:20210520T013145Z LAST-MODIFIED:20220419T001026Z UID:235352-1634747400-1634754600@www.mdgboston.org SUMMARY:Wearable Devices: The New Paradigm of 'Constant' Healthcare DESCRIPTION:Recordings\n \n Forum Recording\n \n \n \n \n \n \n \n \n \n \n \n Full Length\n \n \n \n \n \n \n \n \n \n \n \n \n Highlights Preview\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Abstract\nWearable medical devices continue to improve healthcare\, particularly in the monitoring and management of chronic diseases. There are exciting and substantive advancements in disease treatment and quality of life being developed. Two of our panelists are contributing as entrepreneurs from deep personal connections: they are also patients. John Wilcox has Type I Diabetes and Paulo Zoio is a kidney transplant recipient. Our 3rd panelist\, Ronen Jashek\, will cover other applications of wearable devices in healthcare. \nThis typically forward-looking MDG Boston Forum will provide up-to-date industry knowledge along with development and application insights for other entrepreneurs considering or already advancing their own ‘wearable’ projects in this rapidly growing healthcare sector. \n \n Forum Recording\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n John Wilcox\n Co-Founder & CEO Diatech Diabetes\, Inc \n John was diagnosed with type 1 diabetes at age 9. He became committed to advancing diabetes treatments. In 2018\, he co-founded Diatech Diabetes to develop products to better detect and predict insulin pump infusion failures. \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Paulo Zoio\n PhD student in Biomedical Engineering Technical University of Lisbon \n Paulo became kidney patient in hemodialysis at age 11. He is the co-founder and CTO of Zeevo-Smart Sensing. In 2020\, he won the EIT Digital Venture Prize with his project ‘wearable sensor for kidney disease diagnosis and prognosis’. \n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Ronen Jashek\n COO and Co-Founder Theranica \n An international hi tech executive\, Ronen co-founded Theranica to provide easy-to-use\, non-invasive\, non-pharmacological and affordable wearable therapeutic products.\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Adam Jacobs - MODERATOR\n Chief Technology Officer\, Sunrise Labs \n Adam is a senior level technology leader with proven success in R&D\, medical device development\, and driving product innovation. He has developed many novel technologies including in-vivo and in-vitro diagnostics\, optical and imaging systems automation\, signal processing\, classifiers\, and precision mechanics…read more. \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Tim Stone - EVENT CHAMPION\n Business Development Manager\, Sunrise Labs \n Tim brings value to companies seeking product development and engineering services for medical devices\, combination products\, & life science instrumentation. Sunrise Labs strives to be the preferred development partner for solving unique design challenges and provides innovative solutions for smart products that improve our world and save lives.\n LinkedIn\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Agenda\nOct 20\, 2021: 4:30 pm – 6:30 pm EDT \n\n4:30 – 5:00 General Networking\n5:00 – 6:00 Panelist Forum\n6:00 – 6:30+ Meet the Speakers & More Networking\n\nAll Zoom links for attending the Forum and Networking sessionswill be sent to registered individuals prior to the event. URL:https://www.mdgboston.org/event/wearable-devices/ LOCATION:Online CATEGORIES:Featured,MDG ATTACH;FMTTYPE=image/jpeg:https://www.mdgboston.org/wp-content/uploads/2021/07/MDG_Event-Featured-Image_What-We-Have-Learned-About-Wearable-Devices.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20211014T160000 DTEND;TZID=America/New_York:20211014T170000 DTSTAMP:20220423T151927Z CREATED:20210924T002712Z LAST-MODIFIED:20220423T151927Z UID:239230-1634227200-1634230800@www.mdgboston.org SUMMARY:Top 5 Ways to Achieve Your Business Goals When Designing and Developing a GUI DESCRIPTION:Abstract\nBusiness outcomes are driven by user engagement\, product adoption and/or patient adherence to therapy. These metrics drive increased sales based on a great user or patient experience. GUI’s are the most likely area where there can be major misalignment for business goals: Marketability\, Usability/Safety\, Technology Feasibility.  \nAchieving these success metrics is a team sport and requires a diverse set of stakeholders who agree on a strategy and are following an integrated process. Alex Therrien\, Director of User Centered Design and Jim Turner\, Director of Software Development of Sunrise Labs are hosting this webinar to share many of their best practices for achieving a smooth launch by having all team members aligned on building great user experiences for medical devices within a regulated industry. \nPanelists\n\n\n\n\n \nAlex Therrien\nDirector\, User Centered Design Sunrise Labs\nAlex has over 20 years of experience applying user centered design methods in both consulting and corporate environments. He has led industrial design\, interaction design\, and human factors engineering programs to develop medical devices for home dialysis\, connected drug delivery\, digital health/mobile medical apps\, and surgical procedures.\n\n\n \nJim Turner\nDirector\, Software Engineering Sunrise Labs\nJim has over 30 years of experience in software development\, predominantly in developing solutions for medical devices and telecommunications. Jim’s experience includes leading technical teams creating handheld medical devices\, and in software quality assurance\, validation and verification.\n \n\n\n\n\nThe Zoom link for the Forum will be sent to all registrants prior to the event. URL:https://www.mdgboston.org/event/top-5-ways-to-achieve-your-business-goals-when-designing-and-developing-a-gui/ LOCATION:Online CATEGORIES:Affiliate ATTACH;FMTTYPE=image/png:https://www.mdgboston.org/wp-content/uploads/2021/09/MDG-forum-102021-01-e1644264149874.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20211006T163000 DTEND;TZID=America/New_York:20211006T183000 DTSTAMP:20220419T024321Z CREATED:20210521T151255Z LAST-MODIFIED:20220419T024321Z UID:235377-1633537800-1633545000@www.mdgboston.org SUMMARY:Agile & Adaptive Device Design: Industry CEOs Discuss Lessons Learned and Provide Advice For Growing Companies DESCRIPTION:Recordings\n \n \n \n \n \n \n \n \n \n \n \n Full Length\n \n \n \n \n \n \n \n \n \n \n \n \n Highlights Preview\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Abstract\nCEOs talk about what the medical device design industry learned from the COVID pandemic and how we adapted to become more agile and prepared for the future.\n\nHow companies adapted to a different funding environment\, dominated by less face-to-face discussions?\nHow mundane supply chain issues became a matter of strategic survival?\nHow clinical studies\, inherently face-to-face\, adapted to the new reality?\n\nThe creativity of combining online product development and business activities will carry over into the new business practices.  How much and what is the right balance? \nPanelists\n  \n\n\n\n\n \nChris Leo\nManaging Director\, Back Bay Life Sciences\n\n\n15 years of experience as a strategy consultant leading R&D\, market\, business unit and corporate growth initiatives for leading global biopharma /medtech clients as well as emerging companies with novel\, early-stage technologies.\n\n\n \nDoug Lawrence\nCEO\, Giner Life Sciences\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nExperienced CEO and global business leader\, with a track record of delivering faster-than-market growth\, through new products and global expansion\, especially in Asia. Leveraged marketing\, technology\, and operations to build capabilities that add significant customer value and drive sales growth.\n\n\n \nBryce Klontz\nCEO\, New View Surgical\n\n\n\n\nAn accomplished hands-on leader in the Medical Device industry with strong global business acumen and reliable instincts developed by over 20 years of experience working within the US\, Europe and Asia.\n\n\n\n\n \nKaren Kelley  \nMODERATOR\n\nSenior Co-op Coordinator & Assistant Director\, College of Engineering\, Northeastern University \n\n\n\n \nAlina Ritter  \nEVENT CHAMPION\n\nBusiness Performance Advisor\, Insperity \n\n\n\n\n\nKaren currently serves as a Senior Cooperative Education Faculty Coordinator in Bioengineering Department. She brings over 20 years of experience working as a Coordinator in the ME and IE Co-op Program\nAlina is a Business Performance Advisor with Insperity. She helps small to mid-sized businesses attract and retain top talent\, eliminate tedious HR tasks and stabilize the cost of health benefits. Insperity is a true HR partner that can help mitigate and share the risk of being an employer.\n\n\n\n\n  URL:https://www.mdgboston.org/event/lessons-learned-and-new-post-covid-working-paradigmsagile-adaptive-device-design-industry-ceos-discuss-lessons-learned-and-provide-advice-for-growing-companies/ LOCATION:Online CATEGORIES:Featured,MDG ATTACH;FMTTYPE=image/jpeg:https://www.mdgboston.org/wp-content/uploads/2021/07/MDG_Event-Featured-Image_New-Technology-and-How-We-Operate-Post-Covid.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20210922T163000 DTEND;TZID=America/New_York:20210922T183000 DTSTAMP:20220510T045331Z CREATED:20210520T164704Z LAST-MODIFIED:20220510T045331Z UID:235333-1632328200-1632335400@www.mdgboston.org SUMMARY:Making It Through the Startup Crucible – Serial Entrepreneur CEOs Tell Their Stories DESCRIPTION:Recordings\n \n \n \n \n \n \n \n \n \n \n \n Full Length\n \n \n \n \n \n \n \n \n \n \n \n \n Highlights Preview\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Abstract\nHear CEO’s talk about how they got through the startup process. Our panel will discuss funding\, startup governance\, product development cost and time impacts and share stories reflecting their experiences starting and running medical device companies. From an idea through product development to funding through exit\, we will learn how they did it. \nPanelists\n\n\n\n\n\n\n Amar Sawhney\, PhD \nCEO\, Ocular Therapeutix\, Inc.\n Lishan Aklog\, MD \nCEO\, PAVmed Inc.\n\n\n Martha Shadan\, MBA \nPresident & CEO\,\nMiach Orthopaedics\, Inc.\n Mike Cima\, PhD \nAssociate Dean of Engineering & Co-Director of MIT Innovation Initiative\n\n\n\n\n\n\n\n\n\nVolunteer Champion for this Forum\n\nJeff Karg\nPresident\, MDG Boston\n\n\nWe depend upon and greatly appreciate the work of our member volunteers to help organize\nand present our events.  URL:https://www.mdgboston.org/event/making-it-through-the-startup-crucible-serial-entrepreneur-ceos-tell-their-stories/ LOCATION:Online CATEGORIES:Featured ATTACH;FMTTYPE=image/jpeg:https://www.mdgboston.org/wp-content/uploads/2021/05/meeting-5395567_960_720-3.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20210602T153000 DTEND;TZID=America/New_York:20210602T180000 DTSTAMP:20220510T050008Z CREATED:20210521T153437Z LAST-MODIFIED:20220510T050008Z UID:235386-1622647800-1622656800@www.mdgboston.org SUMMARY:Physician Entrepreneurs - Lessons from the Front Lines DESCRIPTION:Recordings\n \n \n \n \n \n \n \n \n \n \n \n Full Length\n \n \n \n \n \n \n \n \n \n \n \n \n Highlight Preview\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Physician & surgical entrepreneurs play an increasingly important role in medical device development. They have direct familiarity with clinical realities\, unmet needs\, the health delivery culture of their physician & surgical colleagues–and the patients. \n\nLessons learned from a serial physician entrepreneur\nSurgical navigation innovation that combines imagery\, software and iPhones\nNovel treatments for patients in respiratory failure\nDeveloping improved treatment for varicose veins\n\nWhen:\nJune 2\, 2021\n3:30 – 6 PM (EDT) \nWhere:\nOnline\nUnited States \nContact:\nWilliam Munger\nwmunger@mdgboston.org\n617-620-4161 \n\n  \nExceptional clinical entrepreneurs creating innovative products for unmet needs\n  \nPhysician & surgical entrepreneurs play an increasingly important role in medical device development. \nThey have direct familiarity with clinical realities\, unmet needs\, the health delivery culture of their physician & surgical colleagues–and the patients. \nSome fulfill this role in parallel with their clinical career\, while others have embraced a career in industry and venture with great success. \nThis session is moderated by a seasoned executive active in Boston’s MedTech innovation scene. \nWe bring together speakers from both career paths\, with one serial physician entrepreneur providing a retrospective overview of lessons learned\, and three surgeon founders of promising startups developing device-based solutions to support patients with respiratory failure\, varicose veins\, as well as spinal surgery. \n  \nInformative\, insightful founder stories: \n\nLessons learned from a serial physician entrepreneur – doing it more than once.\nSurgical navigation innovation that combines imagery\, software and\, yes\, iPhones\nNovel treatments for patients in respiratory failure–a challenging area of medicine highlighted by COVID this past year\nDeveloping improved treatment for varicose veins–advancing versatility\, convenience\, standardization\, & safety–all at once\n\n  \n  \nWed\, June 2\n3:30 – 6:00 PM (EST)\n3:30 – 4:00 General Networking\n4:00 – 5:30 Panelist Forum\n5:30 – 6:00+ ‘Meet the Speakers’ & More Networking \nForum Fees\n$0 – FREE \n\nJoin us early to network (3:30-4:00)\nLearn from our panelists (4:00-5:30\, including Q&A)\nThen meet & speak with them yourself in our post-Forum Networking session (5:30-6:00+)\n\n  \n\n  \nGabriele Brambilla\, MBA \nCEO\, Alira Health \nMODERATOR \nMr. Brambilla leads Alira Health\, which advises clients on all aspects of medical product development. He serves on several startup boards and co-founded the MetroWest Life Sciences Network. \n  \n  \nSteven Keller\, MD PhD\nAsst. Professor of Medicine\, Division of Pulmonary & Critical Care\, Johns Hopkins Hospital\, Co-Founder of X-COR Therapeutics\, Inc. \nDr. Keller is an Assistant Professor in Pulmonary and Critical Care Medicine at Johns Hopkins University & affiliated faculty at the Harvard-MIT Biomedical Engineering Center. His research is focused on mechanical support of circulatory and respiratory failure\, organ-device interactions\, & extracorporeal organ perfusion. \nTOPIC: Founding story of X-COR Therapeutics\, Inc. – a development stage medical device company working to advance a novel extra-corporeal ventilatory therapy to support patients with respiratory failure \n  \nLishan Aklog\, MD\nChairman & CEO\, PAVmed Inc \nDr. Aklog has been a technology innovator in cardiac surgery at Harvard Medical School and Mt. Sinai School of Medicine. He now leads PAVmed\, a commercial-stage multi-product medical technology company. He previously co-founded four medical device cos. and is on the board of AdvaMed. \nTOPIC: He will discuss his team’s approach to innovation including factors for success\, common hurdles\, and how to access capital. \n  \nEnric Roche\, MD PhD\nHead\, Dept. Vascular Surgery\, Hosp. Univ. Sagrat Cor & H. General de Cataluña \nDr. Roche is a vascular surgeon specializing in venous pathology\, and minimally invasive treatments. His new system for preparation of foam for varicose vein sclerotherapy adds convenience and versatility while advancing standardization and safety. \nTOPIC: An ongoing ‘case history’ story from a founding surgeon who is navigating the business development path for improved therapy of varicose veins. \n  \nJohn Dorman\, MD\nNeurosurgeon at Boulder Neurosurgical & Spine Associates\, Programmer\, Founder of Bolt Surgical Navigation System \nDr. Dorman is a board certified neurosurgeon\, programmer\, and founder of Circinus Medical Technologies. He has developed Bolt\, a novel spinal navigation system. It runs on an off the shelf Apple mobile device\, The goal is 510(k) approval. \nTOPIC: A ‘forefront’ story for our high tech era: Bolt Surgical Navigation combines surgery\, imaging\, software\, and a consumer product\, the iPhone. \n  \n\n  \nJune 2\, 2021 Forum\n \nHighlights Preview Short – Watch on Vimeo URL:https://www.mdgboston.org/event/physician-entrepreneurs-lessons-from-the-front-lines/ LOCATION:Online CATEGORIES:MDG,Past Events ATTACH;FMTTYPE=image/jpeg:https://www.mdgboston.org/wp-content/uploads/2021/05/MDG_Event-Featured-Image_Physician-Entreprenuers.jpg END:VEVENT END:VCALENDAR